openPR Logo
Press release

The Elastomeric Infusion Pumps Market To Get Exposed To Digital Twinning At A CAGR Of 9.0%

06-30-2022 05:48 PM CET | Health & Medicine

Press release from: Persistence Market Research

The Elastomeric Infusion Pumps Market To Get Exposed To Digital

Rising volume of surgical procedures globally as well as increasing need for post-operative analgesics for moderate to severe pain has given rise to augmented demand for elastomeric infusion pumps. The global elastomeric infusion pumps market was valued at US$ 981.5 Mn in 2021, and is set to project a CAGR of to 9% over the forecast period (2022-2030).

Patients displaying the inability to ingest oral analgesics benefit through the adoption of elastomeric infusion pumps, thus supporting the growth of the market, owing to a large rate of intensive care admissions worldwide. Rapid growth as well as rising industrialization activities in emerging economies, including the East African region, territories of Eastern Europe, and Asia Pacific has boosted support for production, research, and development of cost-effective medical devices.

Availability of an established manufacturing setup, low-cost labor, and competent and skilled workers in countries such as China are further providing a push for lucrative growth projections for elastomeric infusion pump manufacturers.

Get Sample Copy of this Report @

Preference toward the adoption and utilization of elastomeric pumps as an alternative to electronic pumps for pain management in hospital and medical settings has gained traction, thus exhibiting a surge to the overall sales value of the global market. Key factors supporting growing adoption of elastomeric infusion pumps include ease of usage, cost effectiveness, discreteness, and lower risk of casualty.

Furthermore, extensive application of elastomeric infusion pumps in oncological care by providing support during the delivery of drugs for chemotherapy at ambulatory care centers and home care settings is likely to propel market growth over the forecast period. Elastomeric infusion pump producers are also progressively building focus on bundling accompanying accessories and IV drugs to increase their penetration into the global market.

Company Profiles:

Baxter International, Inc.
Fresenius Kabi AG
B. Braun Melsungen AG
Ambu A/S
Leventon, S.A.U.
Nipro Corporation
Terumo Corporation
Avanos Medical, Inc.

Request for Methodology @

Key Takeaways from Market Study

By product, continuous rate elastomeric pumps are expected to hold over 68% market value share by the end of 2030.

Pain management was the leading treatment with more than 1/3 market share in 2021.

Hospitals dominated the end user segment with a share of around 39.4% in 2021.

By region, Asia Pacific leads the global market and is estimated to grow 2.1X by 2030.

"Increasing administration of drugs by IV for faster relief and emergence of alternatives for drug administration are set to propel demand growth of elastomeric infusion pumps," says an analyst of Persistence Market Research.

Access Full Report @

Market Competition

Key players such as Avanos Medical & B. Braun Melsungen AG cover a larger share in the market, and seek growth approaches that include the production of novel infusion systems as well as activities of strategic partnerships with other existing players to advance their market scope and penetrate into emerging economies.

In April 2020, B. Braun Medical Inc. announced US FDA-EUA of its Perfusor® Space Syringe Infusion Pump, Outlook® ES Pump systems, and Infusomat® Space Volumetric Infusion Pump.

These pumps are used to treat patients of all ages suffering from COVID-19 by delivering continuous nebulized medications via tracheal route into a nebulizer.

In April 2019, Avanos Medical acquired FDA clearance for its ON-Q Bolus pump, which is used for pain management in patients post-surgery, without using opioids.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the elastomeric infusion pumps market in its latest study, presenting historical demand assessment of 2012 - 2021 and projections for 2022 - 2030.

The research study is based on product (continuous rate elastomeric pumps and variable rate elastomeric pumps), treatment (pain management, antibiotic/antiviral, chemotherapy, and others), and end user (hospitals, ambulatory surgical centers, home care settings, clinics, and others), across five key regions of the world.

Access PMR Exclusive Reports-

Testing Inspection And Certification Market-

8K Technology Market-

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales -

About Us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Elastomeric Infusion Pumps Market To Get Exposed To Digital Twinning At A CAGR Of 9.0% here

News-ID: 2668276 • Views: 199

More Releases from Persistence Market Research

Innovation To Be The Progressive Factor For Karaya Gum Market
The global karaya gum market is expected to witness moderate growth during the forecast period. Growth in revenue of karaya gum is primarily driven by an increase in consumer demand for food with natural ingredients coupled with the continued use of karaya gum in the pharmaceutical industry. According to a recently published report by Persistence Market Research titled "Karaya Gum Market: Global Industry Analysis (2012-2016) & Forecast (2017-2025)," the global
The Sugar Alcohol Market To Have A Technological Escalation In Its Armor
Increasing epidemic of diabetes and obesity has driven the awareness of consumers towards sweet foods and beverages, wherein the demand for products containing artificial sweeteners is dwindling rapidly. In order to add the sweet taste to food products, companies are increasing the use of natural compounds such as sugar alcohols. Food regulatory bodies in different countries are acting as proponents for the growing use of sugar alcohols. In addition, scientific
Innovation Encapsulated In Ecstasy To Drive The RTD/High Strength Premixes Marke …
Changing consumer preferences have played an instrumental role in shaping up the beverage business across the globe. Especially with alcoholic beverages, consumers from different parts of the world are seeking for convenience rather than opting for complicated preparation methods. In addition, prevalent consumption of alcoholic premixes in the upscale consumer community has impacted the attitudes of manufacturers, and companies are bringing expensive products to the market. These products are being
The Decyl Oleate Market To Move Across The Exalted Enigma Backed By Innovation
Decyl oleate is industrially produced by the esterification of fatty alcohols and oleic acid, which is used as an emollient in the composition of cosmetics, hair care, and skin care products. The major application of decyl oleate is in the personal care and pharmaceuticals segment. Growth in the demand for decyl oleate is largely contributed by the increase in skin care consciousness among people. Decyl oleate is produced from two

All 5 Releases